Company Phoenix Life Sciences International Limited
Equities
PLSI
US71910Q1022
Pharmaceuticals
Business Summary
Number of employees: 5
Managers
Managers | Title | Age | Since |
---|---|---|---|
Janelle Marsden
CEO | Chief Executive Officer | - | - |
Lewis Humer
CHM | Chairman | 65 | 24/04/14 |
Stephen Cornford
CIO | Chief Investment Officer | - | - |
David Steinman
LAW | General Counsel | - | 31/01/19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lewis Humer
CHM | Chairman | 65 | 24/04/14 |
Janelle Marsden
CEO | Chief Executive Officer | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,084,582 | 8,644,192 ( 85.72 %) | 0 | 85.72 % |
Company contact information
Phoenix Life Sciences International Ltd.
1810 East Sahara Avenue Suite 215
89139, Las Vegas
+
http://www.phoenixlife.coSector
1st Jan change | Capi. | |
---|---|---|
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B |